What we are reading Pharma Industry Seizes on Pandemic as a Shot at Redemption By ProMarket writers July 6, 2020 Share FacebookTwitterEmail ProMarket writers Popular This Week After Affirmative Action Ends, Minority- and Women-Owned Contractors Face an Uphill Battle AI Exposes Flaws in Copyright’s Focus on Transformativeness in Fair Use American Companies Expect Their Customers To Stay Much Longer. That May Be Making the Economy Less Competitive Domestic Bond Investors Can be a Powerful Constraint on Far-Right Populists No related posts. TagsFinancial Times Share FacebookTwitterEmail Previous articleChina Stocks Surge After State Media Urges Investors to Load UpNext articleAd Boycotts Alone Will Not Curb Big Tech LATEST NEWS AI Exposes Flaws in Copyright’s Focus on Transformativeness in Fair Use After Affirmative Action Ends, Minority- and Women-Owned Contractors Face an Uphill Battle Do Americans Want To Break Up Big Firms? American Companies Expect Their Customers To Stay Much Longer. That May Be Making the Economy Less Competitive Domestic Bond Investors Can be a Powerful Constraint on Far-Right Populists Google’s Search Monopoly Money Will Let It Purchase the AI Market Taking on Corporate Power Requires Deprogramming Corporate Law Occupational Licensing Is Everywhere: Regulating Jobs Across Nations How the Cold War US Military Modeled Itself on Private Business The Dynamic Competition Framework Petit et al. Advocate Is Neither Pro-Enforcement nor Anti-Enforcement. It Doesn’t Exist